Insider trade

CFO sold ~$423K of GILD shares in the open market

Traded Apr 15, 2026 · Filed Apr 16, 2026

~$423K
Reported value · 3,000 sh @ $140.96: 176K
Holds after · shares reported: +5.5%
stock since the trade · S&P 500 +9.2%, $139.77 → $147.50 on Oct 1

Why it stands out

The money chief of Gilead Sciences sold $423K of Gilead Sciences shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Apr 15, 2026
Reporting period: Not applicable
Filed with the SEC: Apr 16, 2026

CFO$100K–$500KPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$422,880

Shares × reported transaction price

Timing vs results

64 days after results of Feb 10, 2026, 22 days before results of May 7, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $139.77 on Apr 15, 2026, 44% above its 52-week low and 10% below its high, after a 5% drop over the previous 30 trading days

52-week range $96.91 (May 9, 2025) to $155.80 (Feb 11, 2026), 73% of the way up, from 250 adjusted closes. 30 trading days earlier: $147.83 on Mar 3, 2026. Describes the past only, not a forecast

Layoff notice nearby

A WARN layoff notice covering 108 workers was filed in California on April 30, 2026.

From the official state WARN list, 15 days after the trade; 1 more notice by the company within 60 days. Shown for timing only; the two filings are separate

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred